Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and Older.
Brance ML, Larroudé MS, Zamora NV, Bagur A, Graf CE, Giacoia E, Diehl M, Somma LF, Schneeberger E, Salerni HH, Rey P, Varsavsky M, González DC, Massari F, Sánchez JA, Galich AM, Berbotto G, García ML, Zanchetta MB, Martínez Muñoz A, Chavero I, Ramirez Stieben LA, Maher MC, Abdala R, Pérez B, De La Vega MC, Mansur JL, Brun LR; On Behalf AAOMM (Argentinean Association of Osteology and Mineral Metabolism), SAO (Argentinean Osteoporosis Society), and SAR (Argentinean Rheumatology Society). Brance ML, et al. Among authors: massari f. J Clin Rheumatol. 2023 Aug 1;29(5):e59-e70. doi: 10.1097/RHU.0000000000001951. Epub 2023 Apr 3. J Clin Rheumatol. 2023. PMID: 37005371
Denosumab: What's new?
Bogado CE, Zanchetta MB, Boailchuk JA, Massari FE, Zanchetta JR. Bogado CE, et al. Curr Osteoporos Rep. 2011 Mar;9(1):12-9. doi: 10.1007/s11914-010-0040-1. Curr Osteoporos Rep. 2011. PMID: 21132405 Review.
Denosumab: an update.
Bogado CE, Boailchuk JA, Zanchetta MB, Massari FE, Zanchetta JR. Bogado CE, et al. Among authors: massari fe. Drugs Today (Barc). 2011 Aug;47(8):605-13. doi: 10.1358/dot.2011.47.8.1603507. Drugs Today (Barc). 2011. PMID: 21850283 Review.
Impaired Bone Microarchitecture Improves After One Year On Gluten-Free Diet: A Prospective Longitudinal HRpQCT Study in Women With Celiac Disease.
Zanchetta MB, Longobardi V, Costa F, Longarini G, Mazure RM, Moreno ML, Vázquez H, Silveira F, Niveloni S, Smecuol E, de la Paz Temprano M, Massari F, Sugai E, González A, Mauriño EC, Bogado C, Zanchetta JR, Bai JC. Zanchetta MB, et al. Among authors: massari f. J Bone Miner Res. 2017 Jan;32(1):135-142. doi: 10.1002/jbmr.2922. Epub 2016 Oct 3. J Bone Miner Res. 2017. PMID: 27447366 Free article. Clinical Trial.
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.
Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A. Langdahl BL, et al. Lancet. 2017 Sep 30;390(10102):1585-1594. doi: 10.1016/S0140-6736(17)31613-6. Epub 2017 Jul 26. Lancet. 2017. PMID: 28755782
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C. Brown JP, et al. Among authors: massari f. J Bone Miner Res. 2021 Nov;36(11):2139-2152. doi: 10.1002/jbmr.4409. Epub 2021 Aug 10. J Bone Miner Res. 2021. PMID: 34190361 Free PMC article. Clinical Trial.
717 results